Addressing Small Data Challenges in Biopharmaceutical Development and Manufacturing: A Mini Review of Multi-Fidelity Techniques

Abstract

The growing demand for biopharmaceutical products reflects their effectiveness in medical treatments. However, developing new biopharmaceuticals remains a major bottleneck, often taking up to a decade before market approval. Machine learning (ML) models have the potential to accelerate this process, but their success depends on access to large and diverse data sets for training. Multi-fidelity ML techniques offer a promising solution by integrating abundant, low-cost, and less accurate low-fidelity (LF) data with limited, expensive, and more accurate high-fidelity (HF) data. In this framework, LF data capture global system trends, while HF data refine and align model predictions with the ava..